Feb 26, 2025 · Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.

Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries.

At Grifols, we are pioneers in the development of therapies derived from blood and plasma. We contribute to building the future of healthcare to improve people's well-being. Since 1909, we have been defined by passion, innovation, teamwork and a sense of responsibility.

Grifols es una compañía global líder en el sector de la salud. Nuestros innovadores medicamentos derivados del plasma, otros productos biofarmacéuticos y soluciones en medicina transfusional permiten mejorar la calidad de vida de millones de pacientes en todo el mundo.

Grifols USA was established in 2003. Based in Los Angeles, we cover the U.S. market where we offer a comprehensive portfolio of Grifols products and services. The company is one of the largest producers of life-saving plasma medicines and other innovative biopharmaceutical solutions in the world.

Grifols treatments center on immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. Each area features therapies helping patients today as well as boundary-pushing research leading to the next groundbreaking discoveries.

Feb 18, 2025 · In 2023, Grifols launched its AlphaID™ At Home service, enabling U.S. adults to screen for the genetic risk of AAT deficiency without prescription from a healthcare professional. Since then, approximately 70,000 tests have been ordered.

Following the recent Capital Markets Day on 27 Feb 2025, Grifols announces it will hold a Non-Deal Roadshow (NDR) for equity investors during the week of March 17th, 2025. The NDR will be commence in New York on March 17th and March 18th, followed by Boston on March 19th and finally London on March 20th and March 21st.

Grifols Deutschland wurde 1997 gegründet. Von Frankfurt aus leiten wir den Biopharma-Vertrieb in Deutschland und den Diagnostic-Vertrieb in den Märkten Deutschland, Österreich und Schweiz (DACH). Wir bieten ein umfassendes Portfolio an Grifols-Produkten und -Services.

Would you like to join an international team working to improve the future of healthcare? Do you want to enhance the lives of millions of people? Grifols is a global healthcare company that since 1909 has been working to improve the health and well-being of people around the world.